Splenic artery ligation ameliorates hepatic ischemia and reperfusion injury in rats

Liver International

Volumn 26, Issue 2, 2006, Pages 254-260

  Ito, Koji ^a,b   Ozasa, Hisashi ^c   Noda, Yumi ^a   Horikawa, Saburo ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TSUCHIURA KYODO GENERAL HOSPITAL   (Japan)

^c Minami Ikebukuro Clinic   (Japan)

Author keywords

Hepatic injury; Ischemia and reperfusion; Splenic artery ligation; Transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYTOKINE; INTERLEUKIN 6; MESSENGER RNA; MYELOPEROXIDASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD VESSEL OCCLUSION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; HISTOPATHOLOGY; LIVER ISCHEMIA; MALE; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SPLEEN ARTERY;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; EMBOLIZATION, THERAPEUTIC; INTERLEUKIN-6; LIGATION; MALE; NEUTROPHILS; PEROXIDASE; RATS; RATS, WISTAR; REPERFUSION INJURY; RNA, MESSENGER; SPLENIC ARTERY;

EID: 33645960674     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01220.x     Document Type: Article

References (25)

1. Thurman R G, Marzi I, Seitz G, et al. Hepatic reperfusion injury following orthotopic liver transplantation in the rat. Transplantation 1988; 46: 502-6.
2. Henderson J M. Liver transplantation and rejection: An overview. Hepatogastroenterology 1999; 46 (Suppl. 2): 1482-4.
3. Colletti L M, Burtch G D, Remick D G, et al. The production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion. Transplantation 1990; 49: 268-73.
4. Colletti L M, Burtch G D, Remick D G, et al. Role of tumor necrosis factor-α in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990; 85: 1936-43.
5. Jaeschke H, Farhood A, Smith C W. Neutrophils contribute to ischemia/ reperfusion injury in rat liver in vivo. FASEB J 1990; 4: 3355-9.
6. Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia reperfusion injury in rat liver. Am J Physiol 1991; 260: G355-62.
7. Jaeschke H, Farhood A, Bautista A P, et al. Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18) monoclonal antibody protects against ischemia-reperfusion injury in rat liver. Hepatology 1993; 17: 915-23.
8. Zhou W, McCollum M O, Levine B A, et al. Inflammation and platelet-activating factor production during hepatic ischemia/ reperfusion. Hepatology 1992; 16: 1236-40.
9. Goto M, Takei Y, Kawano S, et al. Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbance. Hepatology 1994; 19: 675-81.
10. Ito K, Ozasa H, Yoneya R, et al. Splenectomy ameliorates hepatic ischemia and reperfusion injury mediated by heme oxygenase-1 induction in the rat. Liver 2002; 22: 467-73.
11. Welbourn C R B, Goldman G, Paterson I S, et al. Pathophysiology of ischemia reperfusion injury: Central role of the neutrophil. Br J Surg 1991; 78: 651-5.
12. Okuaki Y, Miyazaki H, Zeniya M, et al. Splenectomy reduced hepatic injury induced by ischemia/reperfusion in the rat. Liver 1996; 16: 188-94.
13. Ito K, Ozasa H, Horikawa S. Effects of prior splenectomy on remnant liver after partial hepatectomy with Pringle maneuver in rats. Liver Int 2005; 25: 438-44.
14. Serafin A, Rosello-Catafau J, Prats N, et al. Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol 2002; 161: 587-601.
15. Sugawara Y, Yamamoto J, Shimada K, et al. Splenectomy in patients with hepatocellular carcinoma and hypersplenism. J Am Coll Surg 2000; 190: 446-50.
16. Mukaiya M, Hirata K, Yamashiro K, et al. Changes in portal hemodynamics and hepatic function after partial splenic embolization (PSE) and percutaneous transhepatic obliteration (PTO). Cancer Chemother Pharmacol 1994; 33 (Suppl.): S37-41.
17. Suzuki S, Toledo-Pereyra L H, Rodriguez F J, et al. Neutrophil infiltration as an important factor of liver ischemia and reperfusion injury. Modulating effects of FK 506 and cyclosporine. Transplantation 1993; 55: 1265-72.
18. Chen H M, Shyr M H, Lau Y T, et al. Leukocyte-endothelial adherence correlates with pancreatic nitric oxide production in early caerulein-induced pancreativity in rats. Shock 1998; 10: 218-22.
19. Weiss S J. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-76.
20. Schutze G E, Mason E O Jr, Barson W J, et al. Invasive pneumococcal infections in children with asplenia. Pediatr Infect Dis J 2002; 21: 278-82.
21. Leemans R, Manson W, Snijder J A, et al. Immune response capacity after human splenic autotransplantation: Restoration of response to individual pneumococcal vaccine subtypes. Ann Surg 1999; 229: 279-85.
22. Llende M, Santiago-Delpin E A, Lavergne J. Immunobiological consequences of splenectomy: A review. J Surg Res 1986; 40: 85-94.
23. Man K, Fan S T, Lo C M, et al. Graft injury in relation to graft size in right lobe live donor liver transplantation: A study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression. Ann Surg 2003; 237: 256-64.
24. Shimada M, Ijichi H, Yonemura Y, et al. The impact of splenectomy or splenic artery ligation on the outcome of a living donor adult liver transplantation using a left lobe graft. Hepatogastroenterology 2004; 51: 625-9.
25. Lo C M, Liu C L, Fan S T. Portal hyperperfusion injury as the cause of primary nonfunction in a small-for-size liver graft-successful treatment with splenic artery ligation. Liver Transpl 2003; 9: 626-8.